Mu Xu

4.5k citations
39 papers · 2.5k indexed · 1 hit paper · h-index 21
Topics
Cancer-related molecular mechanisms research (24 papers)MicroRNA in disease regulation (18 papers)Circular RNAs in diseases (18 papers)

In The Last Decade

Mu Xu

38 papers receiving 2.5k citations

Hit Papers

METTL14-mediated N6-methyladenosine modification of SOX4 ...2020202620222024202050100150200250

Peers

Mu Xu
Comparison fields: 5 of 83
  • Molecular Biology 2.1k
  • Cancer Research 2.0k
  • Oncology 235
  • Pulmonary and Respiratory Medicine 191
  • Epidemiology 140
Replace Genta Sawada with:
Genta Sawada Japan
Weiwei Weng China
Ryunosuke Kogo Japan
Yuki Takano Japan
Youtao Xu China
Shujuan Ni China
Dingzhi Huang China
Anbang He China
Xiaojia Huang China
Mu Xu relative to Genta Sawada Japan Genta Sawada's profile →
Citations per field
00.5×
Genta Sawada · 1×
Citations per year

Countries citing papers authored by Mu Xu

Since Specialization
Citations

This map shows the geographic impact of Mu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu Xu more than expected).

Fields of papers citing papers by Mu Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu Xu. The network helps show where Mu Xu may publish in the future.

Co-authorship network of co-authors of Mu Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Mu Xu. A scholar is included among the top collaborators of Mu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mu Xu. Mu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 6
4 8
5 61
6 5
7 2
8
METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancerbreakdown →
280
9 24
10 206
11 161
12 82
13 172
14 237
15 106
16 58
17 238
18 52
19
Secretory expression of HSA/M2e fusion protein in pichia pastoris
1
20 11

About Mu Xu

Mu Xu is a scholar working on Cancer Research, Molecular Biology and Cell Biology, having authored 39 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (24 papers), MicroRNA in disease regulation (18 papers) and Circular RNAs in diseases (18 papers). The work is most often cited by research in Cancer Research (2.0k citations), Molecular Biology (2.1k citations) and Oncology (235 citations). Mu Xu has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Shukui Wang, Xiangxiang Liu, Xiaoxiang Chen, Kaixuan Zeng, Yuqin Pan, Huiling Sun, Bangshun He, Bei Pan, Xueni Xu and Tao Xu. Their work appears in journals such as Nucleic Acids Research, Nano Letters and Molecular Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026